Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

One-Time Fecal Immunochemical Screening for Advanced Colorectal Neoplasia in Patients with CKD (DETECT Study).

Wong G, Hope RL, Howard K, Chapman JR, Castells A, Roger SD, Bourke MJ, Macaskill P, Turner R, Williams G, Lim WH, Lok CE, Diekmann F, Cross NB, Sen S, Allen RDM, Chadban SJ, Pollock CA, Tong A, Teixeira-Pinto A, Yang JYH, Williams N, Au EHK, Kieu A, James L, Craig JC.

J Am Soc Nephrol. 2019 Apr 30. pii: ASN.2018121232. doi: 10.1681/ASN.2018121232. [Epub ahead of print]

PMID:
31040191
2.

Optimising the two-stage randomised trial design when some participants are indifferent in their treatment preferences.

Walter SD, Turner RM, Macaskill P.

Stat Med. 2019 Jun 15;38(13):2317-2331. doi: 10.1002/sim.8119. Epub 2019 Feb 22.

PMID:
30793786
3.

Agreement between digital breast tomosynthesis and pathologic tumour size for staging breast cancer, and comparison with standard mammography.

Marinovich ML, Bernardi D, Macaskill P, Ventriglia A, Sabatino V, Houssami N.

Breast. 2019 Feb;43:59-66. doi: 10.1016/j.breast.2018.11.001. Epub 2018 Nov 10.

PMID:
30466027
4.

Effect of integrating digital breast tomosynthesis (3D-mammography) with acquired or synthetic 2D-mammography on radiologists' true-positive and false-positive detection in a population screening trial: A descriptive study.

Bernardi D, Li T, Pellegrini M, Macaskill P, Valentini M, Fantò C, Ostillio L, Houssami N.

Eur J Radiol. 2018 Sep;106:26-31. doi: 10.1016/j.ejrad.2018.07.008. Epub 2018 Jul 10.

PMID:
30150047
5.

The Validity of Drug Effects on Proteinuria, Albuminuria, Serum Creatinine, and Estimated GFR as Surrogate End Points for ESKD: A Systematic Review.

Palmer SC, Ruospo M, Teixeira-Pinto A, Craig JC, Macaskill P, Strippoli GFM.

Am J Kidney Dis. 2018 Dec;72(6):779-789. doi: 10.1053/j.ajkd.2018.06.011. Epub 2018 Aug 24.

6.

Predicting pain recovery in patients with acute low back pain: Updating and validation of a clinical prediction model.

da Silva T, Macaskill P, Kongsted A, Mills K, Maher CG, Hancock MJ.

Eur J Pain. 2019 Feb;23(2):341-353. doi: 10.1002/ejp.1308. Epub 2018 Sep 24.

PMID:
30144211
7.

Breast Cancer Screening Using Tomosynthesis or Mammography: A Meta-analysis of Cancer Detection and Recall.

Marinovich ML, Hunter KE, Macaskill P, Houssami N.

J Natl Cancer Inst. 2018 Sep 1;110(9):942-949. doi: 10.1093/jnci/djy121.

PMID:
30107542
8.

Systematic review of agreement between tomosynthesis and pathologic tumor size for newly diagnosed breast cancer and comparison with other imaging tests.

Marinovich ML, Macaskill P, Bernardi D, Houssami N.

Expert Rev Med Devices. 2018 Jul;15(7):489-496. doi: 10.1080/17434440.2018.1491306. Epub 2018 Jul 4. Review.

PMID:
29927337
9.
10.

Letter to the Editor: Preference option randomized design (PORD) for comparative effectiveness research: Statistical power for testing comparative effect, preference effect, selection effect, intent-to-treat effect, and overall effect (SMMR, Vol. 28, Issue 2, 2019).

Walter SD, Macaskill P, Turner R, Guyatt G, Cook R, Prasad K.

Stat Methods Med Res. 2019 May;28(5):1597-1598. doi: 10.1177/0962280218767691. Epub 2018 Apr 10. No abstract available.

PMID:
29633629
11.

Comparison of breast cancers detected in the Verona screening program following transition to digital breast tomosynthesis screening with cancers detected at digital mammography screening.

Caumo F, Romanucci G, Hunter K, Zorzi M, Brunelli S, Macaskill P, Houssami N.

Breast Cancer Res Treat. 2018 Jul;170(2):391-397. doi: 10.1007/s10549-018-4756-4. Epub 2018 Mar 20.

PMID:
29557996
12.

Standard deviation and standard error: interpretation, usage and reporting.

Macaskill P.

Med J Aust. 2018 Feb 5;208(2):63-64. No abstract available.

PMID:
29385971
13.

Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement.

McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM; the PRISMA-DTA Group, Clifford T, Cohen JF, Deeks JJ, Gatsonis C, Hooft L, Hunt HA, Hyde CJ, Korevaar DA, Leeflang MMG, Macaskill P, Reitsma JB, Rodin R, Rutjes AWS, Salameh JP, Stevens A, Takwoingi Y, Tonelli M, Weeks L, Whiting P, Willis BH.

JAMA. 2018 Jan 23;319(4):388-396. doi: 10.1001/jama.2017.19163.

PMID:
29362800
14.

Interval breast cancers in the 'screening with tomosynthesis or standard mammography' (STORM) population-based trial.

Houssami N, Bernardi D, Caumo F, Brunelli S, Fantò C, Valentini M, Romanucci G, Gentilini MA, Zorzi M, Macaskill P.

Breast. 2018 Apr;38:150-153. doi: 10.1016/j.breast.2018.01.002. Epub 2018 Jan 9.

PMID:
29328943
15.

Serum lactate cut-offs as a risk stratification tool for in-hospital adverse outcomes in emergency department patients screened for suspected sepsis.

Shetty AL, Thompson K, Byth K, Macaskill P, Green M, Fullick M, Lander H, Iredell J.

BMJ Open. 2018 Jan 5;8(1):e015492. doi: 10.1136/bmjopen-2016-015492.

16.

Diagnostic Accuracy of Noninvasive Fibrosis Scores in a Population of Individuals With a Low Prevalence of Fibrosis.

Mahady SE, Macaskill P, Craig JC, Wong GLH, Chu WCW, Chan HLY, George J, Wong VWS.

Clin Gastroenterol Hepatol. 2017 Sep;15(9):1453-1460.e1. doi: 10.1016/j.cgh.2017.02.031. Epub 2017 Mar 7.

PMID:
28286195
17.

Estimation of treatment preference effects in clinical trials when some participants are indifferent to treatment choice.

Walter SD, Turner RM, Macaskill P, McCaffery KJ, Irwig L.

BMC Med Res Methodol. 2017 Feb 20;17(1):29. doi: 10.1186/s12874-017-0304-x.

18.

Breast cancer detection using single-reading of breast tomosynthesis (3D-mammography) compared to double-reading of 2D-mammography: Evidence from a population-based trial.

Houssami N, Bernardi D, Pellegrini M, Valentini M, Fantò C, Ostillio L, Tuttobene P, Luparia A, Macaskill P.

Cancer Epidemiol. 2017 Apr;47:94-99. doi: 10.1016/j.canep.2017.01.008. Epub 2017 Feb 11.

PMID:
28192742
19.

Predicting recovery in patients with acute low back pain: A Clinical Prediction Model.

da Silva T, Macaskill P, Mills K, Maher C, Williams C, Lin C, Hancock MJ.

Eur J Pain. 2017 Apr;21(4):716-726. doi: 10.1002/ejp.976. Epub 2017 Jan 20.

PMID:
28107604
20.

Diagnostic accuracy of the Ottawa Ankle and Midfoot Rules: a systematic review with meta-analysis.

Beckenkamp PR, Lin CC, Macaskill P, Michaleff ZA, Maher CG, Moseley AM.

Br J Sports Med. 2017 Mar;51(6):504-510. doi: 10.1136/bjsports-2016-096858. Epub 2016 Nov 24. Review.

PMID:
27884861
21.

Obesity and hypertension in Australian young people: results from the Australian Health Survey 2011-2012.

Kim S, Lewis JR, Baur LA, Macaskill P, Craig JC.

Intern Med J. 2017 Feb;47(2):162-169. doi: 10.1111/imj.13298.

PMID:
27761992
22.

Antibodies against HLA-DP recognize broadly expressed epitopes.

Simmons DP, Kafetzi ML, Wood I, Macaskill PC, Milford EL, Guleria I.

Hum Immunol. 2016 Dec;77(12):1128-1139. doi: 10.1016/j.humimm.2016.09.008. Epub 2016 Sep 21.

PMID:
27664843
23.

The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis.

Marinovich ML, Azizi L, Macaskill P, Irwig L, Morrow M, Solin LJ, Houssami N.

Ann Surg Oncol. 2016 Nov;23(12):3811-3821. Epub 2016 Aug 15. Review.

24.

Elevated Liver Enzymes and Mortality in Older Individuals: A Prospective Cohort Study.

Mahady SE, Wong G, Turner RM, Mitchell P, Macaskill P, Craig JC, George J.

J Clin Gastroenterol. 2017 May/Jun;51(5):439-445. doi: 10.1097/MCG.0000000000000622.

PMID:
27479143
25.

Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.

Bernardi D, Macaskill P, Pellegrini M, Valentini M, Fantò C, Ostillio L, Tuttobene P, Luparia A, Houssami N.

Lancet Oncol. 2016 Aug;17(8):1105-1113. doi: 10.1016/S1470-2045(16)30101-2. Epub 2016 Jun 23.

PMID:
27345635
26.

Beginning the trajectory to ESKD in adult life: albuminuria in Australian aboriginal children and adolescents.

Kim S, Macaskill P, Hodson EM, Daylight J, Williams R, Kearns R, Vukasin N, Lyle DM, Craig JC.

Pediatr Nephrol. 2017 Jan;32(1):119-129. Epub 2016 Jun 23.

PMID:
27338727
27.

Awaji criteria improves the diagnostic sensitivity in amyotrophic lateral sclerosis: A systematic review using individual patient data.

Geevasinga N, Loy CT, Menon P, de Carvalho M, Swash M, Schrooten M, Van Damme P, Gawel M, Sonoo M, Higashihara M, Noto Y, Kuwabara S, Kiernan MC, Macaskill P, Vucic S.

Clin Neurophysiol. 2016 Jul;127(7):2684-91. doi: 10.1016/j.clinph.2016.04.005. Epub 2016 Apr 16.

PMID:
27212114
28.

Prevalence of elevated alanine transaminase in Australia and its relationship to metabolic risk factors: A cross-sectional study of 9,447 people.

Mahady SE, Gale J, Macaskill P, Craig JC, George J.

J Gastroenterol Hepatol. 2017 Jan;32(1):169-176. doi: 10.1111/jgh.13434.

PMID:
27144984
29.

Meta-analysis of breast cancer mortality benefit and overdiagnosis adjusted for adherence: improving information on the effects of attending screening mammography.

Jacklyn G, Glasziou P, Macaskill P, Barratt A.

Br J Cancer. 2016 May 24;114(11):1269-76. doi: 10.1038/bjc.2016.90. Epub 2016 Apr 28.

30.

The differential effect of socio-economic status, birth weight and gender on body mass index in Australian Aboriginal Children.

Kim S, Macaskill P, Baur LA, Hodson EM, Daylight J, Williams R, Kearns R, Vukasin N, Lyle DM, Craig JC.

Int J Obes (Lond). 2016 Jul;40(7):1089-95. doi: 10.1038/ijo.2016.71. Epub 2016 Apr 28.

PMID:
27121249
31.

A randomised controlled trial of a code-word enuresis alarm.

Caldwell PH, Sureshkumar P, Kerr MI, Hamilton S, Teixeira-Pinto A, Macaskill P, Craig JC.

Arch Dis Child. 2016 Apr;101(4):326-31. doi: 10.1136/archdischild-2015-308564. Epub 2015 Dec 8.

PMID:
26646854
32.

Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis.

Marinovich ML, Macaskill P, Irwig L, Sardanelli F, Mamounas E, von Minckwitz G, Guarneri V, Partridge SC, Wright FC, Choi JH, Bhattacharyya M, Martincich L, Yeh E, Londero V, Houssami N.

BMC Cancer. 2015 Oct 8;15:662. doi: 10.1186/s12885-015-1664-4.

33.
34.

Cancer-Specific and All-Cause Mortality in Kidney Transplant Recipients With and Without Previous Cancer.

Viecelli AK, Lim WH, Macaskill P, Chapman JR, Craig JC, Clayton P, Cohney S, Carroll R, Wong G.

Transplantation. 2015 Dec;99(12):2586-92. doi: 10.1097/TP.0000000000000760.

PMID:
26102612
35.

Lack of Accuracy of Body Temperature for Detecting Serious Bacterial Infection in Febrile Episodes.

De S, Williams GJ, Teixeira-Pinto A, Macaskill P, McCaskill M, Isaacs D, Craig JC.

Pediatr Infect Dis J. 2015 Sep;34(9):940-4. doi: 10.1097/INF.0000000000000771.

PMID:
26065864
36.

Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis.

Palmer SC, Teixeira-Pinto A, Saglimbene V, Craig JC, Macaskill P, Tonelli M, de Berardis G, Ruospo M, Strippoli GF.

Am J Kidney Dis. 2015 Dec;66(6):962-71. doi: 10.1053/j.ajkd.2015.03.036. Epub 2015 May 21. Review.

37.

Republished: value of white cell count in predicting serious bacterial infection in febrile children under 5 years of age.

De S, Williams GJ, Hayen A, Macaskill P, McCaskill M, Isaacs D, Craig JC.

Postgrad Med J. 2015 Mar;91(1073):493-9. doi: 10.1136/postgradmedj-2013-304754rep.

PMID:
25740320
38.

Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration.

Moons KG, Altman DG, Reitsma JB, Ioannidis JP, Macaskill P, Steyerberg EW, Vickers AJ, Ransohoff DF, Collins GS.

Ann Intern Med. 2015 Jan 6;162(1):W1-73. doi: 10.7326/M14-0698.

PMID:
25560730
39.

Accuracy of ultrasound for predicting pathologic response during neoadjuvant therapy for breast cancer.

Marinovich ML, Houssami N, Macaskill P, von Minckwitz G, Blohmer JU, Irwig L.

Int J Cancer. 2015 Jun 1;136(11):2730-7. doi: 10.1002/ijc.29323. Epub 2014 Nov 25.

40.

Red flags to screen for malignancy and fracture in patients with low back pain.

Downie A, Williams CM, Henschke N, Hancock MJ, Ostelo RW, de Vet HC, Macaskill P, Irwig L, van Tulder MW, Koes BW, Maher CG.

Br J Sports Med. 2014 Oct;48(20):1518. doi: 10.1136/bjsports-2014-f7095rep.

PMID:
25257627
41.

Beyond the treatment effect: Evaluating the effects of patient preferences in randomised trials.

Walter SD, Turner R, Macaskill P, McCaffery KJ, Irwig L.

Stat Methods Med Res. 2017 Feb;26(1):489-507. doi: 10.1177/0962280214550516. Epub 2016 Jul 11.

PMID:
25213116
42.

An assessment of the relationship between clinical utility and predictive ability measures and the impact of mean risk in the population.

McGeechan K, Macaskill P, Irwig L, Bossuyt PM.

BMC Med Res Methodol. 2014 Jul 3;14:86. doi: 10.1186/1471-2288-14-86.

43.

Breast screening using 2D-mammography or integrating digital breast tomosynthesis (3D-mammography) for single-reading or double-reading--evidence to guide future screening strategies.

Houssami N, Macaskill P, Bernardi D, Caumo F, Pellegrini M, Brunelli S, Tuttobene P, Bricolo P, Fantò C, Valentini M, Ciatto S.

Eur J Cancer. 2014 Jul;50(10):1799-1807. doi: 10.1016/j.ejca.2014.03.017. Epub 2014 Apr 17.

44.

Sample Size and Power When Designing a Randomized Trial for the Estimation of Treatment, Selection, and Preference Effects.

Turner RM, Walter SD, Macaskill P, McCaffery KJ, Irwig L.

Med Decis Making. 2014 Aug;34(6):711-9. doi: 10.1177/0272989X14525264. Epub 2014 Apr 2.

PMID:
24695962
45.

Effect of integrating 3D-mammography (digital breast tomosynthesis) with 2D-mammography on radiologists' true-positive and false-positive detection in a population breast screening trial.

Bernardi D, Caumo F, Macaskill P, Ciatto S, Pellegrini M, Brunelli S, Tuttobene P, Bricolo P, Fantò C, Valentini M, Montemezzi S, Houssami N.

Eur J Cancer. 2014 May;50(7):1232-8. doi: 10.1016/j.ejca.2014.02.004. Epub 2014 Feb 28.

PMID:
24582915
46.

The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis.

Houssami N, Macaskill P, Marinovich ML, Morrow M.

Ann Surg Oncol. 2014 Mar;21(3):717-30. doi: 10.1245/s10434-014-3480-5. Epub 2014 Jan 29.

47.

Value of white cell count in predicting serious bacterial infection in febrile children under 5 years of age.

De S, Williams GJ, Hayen A, Macaskill P, McCaskill M, Isaacs D, Craig JC.

Arch Dis Child. 2014 Jun;99(6):493-9. doi: 10.1136/archdischild-2013-304754. Epub 2014 Jan 9.

PMID:
24406804
48.

An individual person data meta-analysis of preoperative magnetic resonance imaging and breast cancer recurrence.

Houssami N, Turner R, Macaskill P, Turnbull LW, McCready DR, Tuttle TM, Vapiwala N, Solin LJ.

J Clin Oncol. 2014 Feb 10;32(5):392-401. doi: 10.1200/JCO.2013.52.7515. Epub 2014 Jan 6.

PMID:
24395846
49.

Red flags to screen for malignancy and fracture in patients with low back pain: systematic review.

Downie A, Williams CM, Henschke N, Hancock MJ, Ostelo RW, de Vet HC, Macaskill P, Irwig L, van Tulder MW, Koes BW, Maher CG.

BMJ. 2013 Dec 11;347:f7095. doi: 10.1136/bmj.f7095. Review. Erratum in: BMJ. 2014;348:g7.

50.

Incremental effect from integrating 3D-mammography (tomosynthesis) with 2D-mammography: Increased breast cancer detection evident for screening centres in a population-based trial.

Caumo F, Bernardi D, Ciatto S, Macaskill P, Pellegrini M, Brunelli S, Tuttobene P, Bricolo P, Fantò C, Valentini M, Montemezzi S, Houssami N.

Breast. 2014 Feb;23(1):76-80. doi: 10.1016/j.breast.2013.11.006. Epub 2013 Dec 6.

PMID:
24316152

Supplemental Content

Loading ...
Support Center